CI
BMY icon

Capital International’s Bristol-Myers Squibb BMY Stock Holding History

Capital International’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
57,368
+2,483
+5% +$143K 0.11% 132
2026
Q1 		$3.33M Hold
54,885
– – 0.12% 123
2025
Q4 		$2.96M Sell
54,885
-6,090
-10% -$293K 0.1% 127
2025
Q3 		$2.75M Hold
60,975
– – 0.1% 128
2025
Q2 		$2.82M Hold
60,975
– – 0.11% 130
2025
Q1 		$3.72M Buy
60,975
+795
+1% +$46.3K 0.16% 113
2024
Q4 		$3.4M Buy
60,180
+452
+0.8% +$25.3K 0.14% 120
2024
Q3 		$3.09M Buy
+59,728
New +$2.8M 0.13% 122
2024
Q2 		– Sell
-202,304
Closed -$11M – 145
2024
Q1 		$11M Sell
202,304
-5,487
-3% -$280K 0.52% 61
2023
Q4 		$10.7M Sell
207,791
-5,352
-3% -$281K 0.55% 65
2023
Q3 		$12.4M Buy
213,143
+7,349
+4% +$450K 0.71% 46
2023
Q2 		$13.2M Buy
205,794
+35,272
+21% +$2.37M 0.74% 43
2023
Q1 		$11.8M Buy
170,522
+32,222
+23% +$2.27M 0.71% 48
2022
Q4 		$9.95M Buy
138,300
+5,782
+4% +$436K 0.69% 52
2022
Q3 		$9.42M Buy
132,518
+61,316
+86% +$4.45M 0.66% 48
2022
Q2 		$5.48M Buy
71,202
+17,443
+32% +$1.33M 0.41% 72
2022
Q1 		$3.93M Buy
+53,759
New +$3.61M 0.22% 108
2015
Q3 		– Sell
-361,615
Closed -$24.1M – 185
2015
Q2 		$24.1M Sell
361,615
-352,635
-49% -$23.2M 1.42% 22
2015
Q1 		$46.1M Sell
714,250
-55,550
-7% -$3.48M 2.81% 4
2014
Q4 		$45.4M Sell
769,800
-70,300
-8% -$3.96M 2.77% 4
2014
Q3 		$43M Sell
840,100
-35,200
-4% -$1.76M 2.67% 4
2014
Q2 		$42.5M Sell
875,300
-267,900
-23% -$13.2M 2.63% 4
2014
Q1 		$59.4M Buy
1,143,200
+4,900
+0.4% +$261K 3.72% 2
2013
Q4 		$60.5M Sell
1,138,300
-73,300
-6% -$3.73M 3.7% 3
2013
Q3 		$56.1M Sell
1,211,600
-333,500
-22% -$14.6M 3.68% 2
2013
Q2 		$69.1M Buy
+1,545,100
New +$67.1M 4.26% 2

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International's BMY Position: Q2 2026 in Review

Capital International increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q2 2026, buying an estimated $143K and bringing the position to 57,368 shares worth $3.31M. The position accounts for 0.11% of the portfolio, ranked #132.

Capital International first reported a position in BMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $69.1M in Q2 2013. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Capital International held 57,368 shares of Bristol-Myers Squibb worth $3.31M as of Q2 2026.
  • Capital International bought 2,483 Bristol-Myers Squibb shares in Q2 2026, an estimated $143K.
  • Bristol-Myers Squibb made up 0.11% of Capital International's portfolio in Q2 2026, its #132 holding.
  • Capital International first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 26 quarters since.
  • Capital International's Bristol-Myers Squibb position peaked at $69.1M in Q2 2013.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.